Inicio/Acciones/TEVA

TEVA

USD

Teva Pharmaceutical Industries Limited American Depositary Shares

$20.460+0.200 (0.987%)

Precio en Tiempo Real

Healthcare

Drug Manufacturers - Specialty & Generic

Israel

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado

Fundamentos de la Empresa

Estadísticas de Negociación

Métricas de Mercado

Apertura

$20.260

Máximo

$20.718

Mínimo

$20.110

Volumen

22.25M

Fundamentos de la Empresa

Capitalización de Mercado

23.6B

Industria

Drug Manufacturers - Specialty & Generic

País

Israel

Estadísticas de Negociación

Volumen Promedio

10.04M

Bolsa

NYQ

Moneda

USD

Rango de 52 Semanas

Mínimo $12.47Actual $20.460Máximo $22.8

Noticias Relacionadas

3 nov 2025 · 13:00

GlobeNewswire

Teva Kicks Off 'The Other TD' to Raise Awareness of Tardive Dyskinesia (TD), with Support from Pro Football Hall of Famer Terrell Davis

This football season, Teva is increasing education around tardive dyskinesia (TD) by launching ‘The Other TD' campaignTD is a chronic movement disorder impacting one in four people who take certain prescription mental

Teva Kicks Off 'The Other TD' to Raise Awareness of Tardive Dyskinesia (TD), with Support from Pro Football Hall of Famer Terrell Davis

31 oct 2025 · 20:30

GlobeNewswire

Teva to Present at UBS Global Healthcare Conference and Jefferies London Healthcare Conference in November

TEL AVIV, Israel, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at two upcoming investor